Congenital adrenal hyperplasia in the adult patient

Advances in Internal Medicine

Volumn 44, Issue , 1999, Pages 155-173

  Miller, Walter L ^a,b  

^a Metabolic Research Unit   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE;

ADULT; CONGENITAL ADRENAL HYPERPLASIA; FEMALE; GENETICS; HUMAN; INCIDENCE; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; SEXUAL BEHAVIOR;

3-HYDROXYSTEROID DEHYDROGENASES; ADRENAL HYPERPLASIA, CONGENITAL; ADULT; FEMALE; HUMANS; INCIDENCE; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; SEXUAL BEHAVIOR;

EID: 0032601451     PISSN: 00652822     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Miller WL, Tyrrell JB: The adrenal cortex, in Felig P, Baxter J, Frohman L (eds): Endocrinology and Metabolism. New York, McGraw Hill, 1995, pp 555-717.
2. Kominami S, Ochi H, Kobayashi Y, et al: Studies on the steroid hydroxylation system in adrenal cortex microsomes: Purification and characterization of cytochrome P450 specific for steroid 21 hydroxylation. JBiol Chem 255:3386-3394, 1980.
3. Mellon SH, Miller WL: Extra-adrenal steroid 21-hydroxylation is not mediated by P450c21. J Clin Invest 84:1497-1502, 1989.
4. Casey ML, MacDonald PC: Extra-adrenal formation of a mineralocorticoid: Deoxycorticosterone and deoxycorticosterone sulfate biosynthesis and metabolism. Endocr Rev 3:396-403, 1982.
5. Speiser PW, Agdere L, Veshiba H, et al: Aldosterone synthesis in patients with salt-wasting congenital adrenal hyperplasia (21hydroxylase deficiency) and complete absence of adrenal 21hydroxylase (P450c21). N Engl J Med 321:145-149, 1991.
6. Carroll MC, Campbell RD, Porter RR: Mapping of steroid 21hydroxylase genes to complement component C4 genes in HLA, the major histocompatibility locus in man. Proc Natl Acad Sei USA 82:521-525, 1985.
7. White PC, Grossberger D, Onufer B], et al: Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man. Proc Natl Acad Sei USA 82:10891093, 1985.
8. Bristow J, Tee MK, Gitelman SE, et al: Tenascin-X. A novel extracellular matrix protein encoded by the human XB gene overlapping P450c2lB. J Cell Biol 122:265-278, 1993.
9. Burch GH, Gong Y, Liu W, et al: Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nat Genet 17:104-108, 1997.
10. Higashi Y, Yoshioka H, Yamane M, et al: Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: A pseudogene and genuine gene. Proc Natl Acad Sei USA 83:2841-2845, 1986.
11. White PC, New MI, Dupont B: Structure of the human steroid 21-hydroxylase genes. Proc Natl Acad Sei USA 83:5111-5115, 1986.
12. Rodrigues NR, Dunham I, Yu CY, et al: Molecular characterization of the HLA-linked steroid 21-hydroxylase B gene from an individual with congenital adrenal hyperplasia. EMBO J 6:1653-1661, 1987.
13. Bristow J, Gitelman SE, Tee MK, et al: Abundant adrenal-specific transcription of the human P450c21A "pseudogene." J Biol Chem 268:12919-12924, 1993.
14. Chang SF, Chung B: Difference in transcriptional activity of two homologous CYP21A genes. Mol Endocrinol 9:1330-1336, 1995.
15. Donohoue PA, Wedell A: Normal and CAH mutant 21-hydroxylase promoter activities differ in an in vitro luciferase promoter assay. Harm Res 48:978, 1997.
16. Matteson KJ, Phillips JA III, Miller WL, et al: P450XXI (steroid 21-hydroxylase) gene deletions are not found in family studies of congenital adrenal hyperplasia. Proc Natl Acad Sei USA 84:5858-5862, 1987.
17. Miller WL, Morel Y: Molecular genetics of 21-hydroxylase deficiency. Annu Rev Genet 23:371-393, 1989.
18. Speiser PW, Dupont J, Zhu D, et al: Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest 90:584-595, 1992.
19. Tusie-Luna MT, White PC: Gene conversions and unequal crossovers between CYP21 (steroid 21-hydroxylase gene) and CYP21P involve different mechanisms. Proc Natl Acad Sei USA 92:10796-10800, 1995.
20. Morel Y, Miller WL: Clinical and molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Adv Hum Genet 20:1-68, 1991.
21. Wedell A, Thilén A, Ritzen EM, et al: Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: Implications for genetic diagnosis and association with disease manifestation. J Clin Endocrinol Metab 78:1145-1152, 1994.
22. Wilson RC, Wei J-Q, Cheang KG, et al: Rapid DMA analysis by allelespecific PCR for detection of mutations in the steroid 21-hydroxylase gene. J Clin Endocrinol Metab 80:1635-1640, 1995.
23. Harada F, Kimura A, Iwanaga T, et al: Gene conversion-like events cause steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia. Proc Natl Acad Sei USA 84:8091-8094, 1987.
24. Higashi Y, Tanae A, Inoue H, et al: Evidence for frequent gene conversions in the steroid 21-hydroxylase (P-450c21) gene: Implications for steroid 21-hydroxylase deficiency. Am J Hum Genet 42:17-25, 1988.
25. Amor M, Parker KL, Globerman H, et al: Mutation in the CYP21B gene (Ile-172-Asn) causes steroid 21-hydroxylase deficiency. Proc Natl Acad Sei USA 85:1600-1604, 1988.
26. Globerman H, Amor M, Parker PL, et al: Nonsense mutation causing steroid 21-hydroxylase deficiency. J Clin Invest 82:139-144, 1988.
27. Auchus RJ, Lee TC, Miller WL: Cytochrome b5 augments the 17,20 lyase activity of human P450cl7 without direct electron transfer. JBiol Chem 273:3158-3165, 1998.
28. Fiet J, Gueux B, Gourmelen M, et al: Comparison of basal and adrenocorticotropin-stimulated plasma 21-desoxycortisol and 17hydroprogesterone values as biological markers of late-onset adrenal hyperplasia. J Clin Endocrinol Metab 66:659-667, 1988.
29. Miller WL: Genetics, diagnosis, and management of 21-hydroxylase deficiency. J Clin Endocrinol Metab 78:241-246, 1994.
30. Pang S, Wallace MA, Hofman L, et al: Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21hydroxylase deficiency. Pediatrics 81:866-874, 1988.
31. Therrell BL Jr, Berenbaum SA, Manter-Kapanke V, et al: Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Pediatrics 101:583-590, 1998.
32. Speiser PW, Dupont B, Rubinstein P, et al: High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet 37:650-667, 1985.
33. Migeon CJ, Rosenwask Z, Lee PA, et al: The attenuated form of congenital adrenal hyperplasia as an allelic form of 21-hydroxylase deficiency. 7 Clin Endocrinol Metab 51:647-649, 1980.
34. Kohn B, Levine LS, Pollack MS, et al: Late-onset steroid 21hydroxylase deficiency: A variant of classical congenital adrenal hyperplasia. 7 Clin Endocrinol Metab 51:817-827, 1982.
35. Chrousos GP, Loriaux DL, Mann DL, et al: Late-onset 21-hydroxylase deficiency mimicking idiopathic hirsutism or polycystic ovarian disease: An allelic variant of congenital virilizing adrenal hyperplasia with a milder enzymatic defect. Ann Intern Med 96:143-148, 1982.
36. Chetkowski RJ, DeFazio J, Shamonki I, et al: The incidence of the lateonset congenital adrenal hyperplasia due to 21-hydroxylase deficiency among hirsute women. J Clin Endocrinol Metab 58:595-598, 1984.
37. Kuttenn F, Couillin P, Girard F, et al: Late-onset adrenal hyperplasia in hirsutism. N Engl J Med 313:222-231, 1985.
38. Azziz R, Dewailly D, Owerbach D: Nonclassic adrenal hyperplasia: Current concepts. J Clin Endocrinol Metab 78:810-815, 1994.
39. Azziz R, Zacur A: 21-Hydroxylase deficiency in female hyperandrogenism: Screening and diagnosis. J Clin Endocrinol Metab 69:577-584, 1989.
40. Dunaif A: Hyperandrogenic anovulation (PCOS): A unique disorder of insulin action associated with an increased risk of non-insulindependent diabetes mellitus. AmJMed 98:33S-39S, 1995.
41. Levine LS, Dupont B, Lorenzen F, et al: Genetic and hormonal characterization of the cryptic 21-hydroxylase deficiency. J Clin Endocrinol Metab 53:1193-1198, 1981.
42. New MI, Lorenzen F, Lerner AJ, et al: Genotyping steroid 21hydroxylase deficiency: Hormonal reference data. J Clin Endocrinol Metab 57:320-326, 1983.
43. Günther DF, Bukowski TP, Ritzen EM, et al: Prophylactic adrenalectomy of a three-year-old girl with congenital adrenal hyperplasia: Preand postoperative studies. J Clin Endocrinol Metab 82:3324-3327, 1997.
44. Laue L, Merke DP, Jones JV, et al: A preliminary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia. J Clin Endocrinol Metab 81:3535-3539, 1996.
45. Grumbach MM, Conte FA: Disorders of sexual differentiation, in Wilson JD, Foster D (eds): Williams' Textbook of Endocrinology. Philadelphia, 1992, pp 853-952.
46. Mulaikal RM, Migeon CJ, Rock JA: Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl JMed 316:178-182, 1987.
47. Dittmann RW, Kappes ME, Kappes MH: Sexual behavior in adolescent and adult females with congenital adrenal hyperplasia. Psychoneuroendocrinology 17:153-170, 1992.
48. Kuhnle U, Bollinger M, Schwarz HP, et al: Partnership and sexuality in adult female patients with congenital adrenal hyperplasia. First results of a cross-sectional quality-of-life evaluation. J Steroid Biochem Mol Biol 45:123-126, 1993.
49. Zucker KJ, Bradley SJ, Oliver G, et al: Psychosexual development of women with congenital adrenal hyperplasia. Harm Behav 30:300-318, 1996.
50. Meyer-Bahlburg HFL, Gruen RS, New MI, et al: Gender change from female to male in classical congenital adrenal hyperplasia. Horm Behav 30:319-332, 1996.
51. Schwitzgebel VM, Kaplan SL, Grumbach MM, et al: Normal female offspring in mothers with salt-losing form of 21-hydroxylase deficiency. Horm Res 48:33S, 1997.
52. White PC, Mune T, Agarwal AK: ll-hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr Rev 18:135-156, 1997.
53. Forest MG, David M, Morel Y: Prenatal diagnosis and treatment of 21hydroxylase deficiency. J Steroid Biochem Mol Biol 45:75-82, 1993.
54. Speiser PW, New MI: Prenatal diagnosis and management of congenital adrenal hyperplasia. Clin Perinatal 21:631-645, 1994.
55. Mercado AB, Wilson RC, Cheng KG, et al: Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. J Clin Endocrinol Metab 80:2014-2020, 1995.
56. Seckl JR, Miller WL: How safe is long-term prenatal glucocorticoid treatment? JAMA 277:1077-1079, 1997.
57. Miller WL: Prenatal treatment of congenital adrenal hyperplasia-a promising experimental therapy of unproven safety. Trends Endocrinol Metab 9:290-293, 1998.
58. Simard J, Rhéaume E, Sanchez R, et al: Molecular basis of congenital adrenal hyperplasia due to 3-hydroxysteroid dehydrogenase deficiency. Mol Endocrinol 7:716-728, 1993.
59. Pang S, Pollack MS, Loo M, et al: Pitfalls of prenatal diagnosis of 21hydroxylase deficiency congenital adrenal hyperplasia. J Clin Endocrinol Metab 61:89, 1985.
60. Azziz R, Bradley ELJ, Potter HD, et al: 3-hydroxysteroid dehydrogenase deficiency in hyperandrogenism. Am J Obstet Gynecol 168:889895, 1993.
61. Chang YT, Zhang L, Alkaddour HS, et al: Absence of molecular defect in the Type II 3-hydroxysteroid dehydrogenase (3-HSD) gene in premature pubarche children and hirsute female patients with moderately decreased adrenal 3-HSD activity. Pediatr Res 37:820-824, 1995.
62. Sakkal-Alkaddour H, Zhang L, Yang X, et al: Studies of 3hydroxysteroid dehydrogenase genes in infants and children manifesting premature pubarche and increased adrenocorticotropinstimulated A5-steroid levels. J Clin Endocrinol Metab 81:3961-3965, 1996.
63. Pang S: The molecular and clinical spectrum of 3-hydroxysteroid dehydrogenase deficiency disorder. Trends Endocrinol Metab 9:82-86, 1998.